CIK 0000943819
- Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980152841
- Phone
- +1 858-746-2400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-11 | PENDARVIS DAVID Chief Administrative Officer | Option exercise | +983 | $101.64 | $100K | 120,485 |
| 2021-11-11 | PENDARVIS DAVID Chief Administrative Officer | Gift | −10,000 | 110,485 | ||
| 2021-11-11 | PENDARVIS DAVID Chief Administrative Officer | Option exercise · ResMed Common Stock Options | −983 | 18,468 | ||
| 2021-11-11 | Hollingshead James President, Sleep Business | Shares withheld for taxes | −4,100 | $259.47 | $1.1M | 69,112 |
| 2021-11-11 | Ghoshal Kaushik President, SaaS Business | Shares withheld for taxes | −976 | $259.47 | $253K | 6,424 |
| 2021-11-11 | FARRELL PETER C Director | Shares withheld for taxes | −342 | $259.47 | $89K | 191,624 |
| 2021-11-11 | De Witte Jan Director | Shares withheld for taxes | −104 | $259.47 | $27K | 4,033 |
| 2021-11-11 | Farrell Michael J. Chief Executive Officer | Shares withheld for taxes | −8,748 | $259.47 | $2.3M | 415,958 |
| 2021-11-10 | Sandercock Brett Chief Financial Officer | Option exercise | +2,500 | $57.76 | $144K | 87,333 |
| 2021-11-10 | Sandercock Brett Chief Financial Officer | Sale | −2,500 | $260.58 | $651K | 84,833 |
| 2021-11-10 | Sandercock Brett Chief Financial Officer | Option exercise · ResMed Common Stock Options | −2,500 | 22,500 | ||
| 2021-11-03 | PENDARVIS DAVID Chief Administrative Officer | Sale | −1,485 | $264.29 | $392K | 120,987 |
| 2021-11-01 | Hollingshead James President, Sleep Business | Sale | −2,400 | $264.35 | $634K | 73,177 |
| 2021-10-15 | Douglas Robert Andrew President and COO ResMed Inc. | Option exercise | +8,000 | $58.24 | $466K | 30,149 |
| 2021-10-15 | Douglas Robert Andrew President and COO ResMed Inc. | Sale | −8,000 | $255.77 | $2.0M | 22,149 |
| 2021-10-15 | Douglas Robert Andrew President and COO ResMed Inc. | Option exercise · ResMed Common Stock Options | −8,000 | 102,098 | ||
| 2021-10-11 | Sandercock Brett Chief Financial Officer | Option exercise | +2,500 | $57.76 | $144K | 89,786 |
| 2021-10-11 | Sandercock Brett Chief Financial Officer | Sale | −5,000 | $253.37 | $1.3M | 84,786 |
| 2021-10-11 | Sandercock Brett Chief Financial Officer | Option exercise · ResMed Common Stock Options | −2,500 | 25,000 | ||
| 2021-10-08 | Hollingshead James President, Sleep Business | Shares withheld for taxes | −234 | $246.52 | $58K | 75,577 |
Page 33 of 37 · 721 trades